Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

17.6%

9 terminated/withdrawn out of 51 trials

Success Rate

81.3%

-5.3% vs industry average

Late-Stage Pipeline

4%

2 trials in Phase 3/4

Results Transparency

79%

31 of 39 completed trials have results

Key Signals

1 recruiting31 with results7 terminated

Enrollment Performance

Analytics

N/A
36(85.7%)
Phase 2
3(7.1%)
Early Phase 1
1(2.4%)
Phase 3
1(2.4%)
Phase 4
1(2.4%)
42Total
N/A(36)
Phase 2(3)
Early Phase 1(1)
Phase 3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (51)

Showing 20 of 51 trials
NCT04484220Not ApplicableCompleted

Ellipsys Vascular Access System Post Market Surveillance (PS) Study

Role: lead

NCT06742801Not ApplicableRecruiting

Onyx™ Liquid Embolic IDE Clinical Study

Role: lead

NCT07335341Not Yet Recruiting

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

Role: lead

NCT03820947Not ApplicableTerminated

VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial

Role: lead

NCT02963649Not ApplicableCompleted

IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA

Role: lead

NCT04120610Terminated

FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia

Role: lead

NCT03041467Not ApplicableCompleted

IN.PACT™ AV Access IDE Study

Role: lead

NCT03038438Not ApplicableCompleted

ABRE Clinical Study of the Abre Venous Self-expanding Stent System

Role: lead

NCT03869645Terminated

CAPERE Thrombectomy System Post-Market Clinical Follow Up Study

Role: lead

NCT04494035Not ApplicableTerminated

AVATR - Arteriovenous Access Thrombosis Removal With CAPERE Thrombectomy System

Role: lead

NCT05455554Unknown

The Use of FlowMet-R Technology to Predict Wound Healing in CLI Patients in a Wound Care Center Setting

Role: collaborator

NCT02363972Not ApplicableCompleted

Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD

Role: lead

NCT00619775Phase 3Completed

Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial

Role: lead

NCT00720577Early Phase 1Completed

Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.

Role: lead

NCT04282161Not ApplicableWithdrawn

Pivotal Study of the Medtronic Axys EX Rotational Atherectomy System

Role: lead

NCT01609296Not ApplicableCompleted

IN.PACT Global Clinical Study

Role: lead

NCT03454113Completed

Ellipsys Vascular Access System Registry

Role: lead

NCT02816398Not ApplicableCompleted

Catheter System Feasibility Clinical Trial

Role: lead

NCT01680835Not ApplicableCompleted

EverFlex Post Approval Study

Role: lead

NCT00883246Not ApplicableCompleted

Study of SilverHawk®/TurboHawk® in Lower Extremity Vessels (DEFINITIVE™ LE)

Role: lead